SCHEMBL4520041

SCHEMBL4520041

CON(C(C)=O)c1ccc(/C=C/C(=O)c2c(O)c3cccnc3n(C)c2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.41
KDM4E B2RXH2 6/20 0.41
RAB9A P51151 6/20 0.41
KMT2A Q03164 4/20 0.41
NQO1 P15559 3/20 0.41
MEN1 O00255 3/20 0.41
RECQL P46063 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
PADI4 Q9UM07 4/20 0.40
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
FEN1 P39748 1/20 0.35
NPC1 O15118 5/20 0.35
ALDH1A1 P00352 4/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 2/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4522124 0.90 NQO1 (0.37) MAPTKDM4ERAB9ANQO1PADI4
SCHEMBL3495642 0.86 PADI4 (0.35) MAPTKDM4ERAB9APADI4FEN1
SCHEMBL4520046 0.78 GAA (0.40) MAPTKDM4ERAB9AKMT2AMEN1
SCHEMBL4527553 0.74 BCHE (0.44) KDM4ENQO1ALDH1A1LMNAABCG2
SCHEMBL4510109 0.74 CYSLTR2 (0.44) NQO1CYP1A2ALDH1A1LMNAL3MBTL1
SCHEMBL4527547 0.74 BCHE (0.44) KDM4ENQO1ALDH1A1LMNAABCG2
SCHEMBL4510106 0.74 CYSLTR2 (0.44) NQO1CYP1A2ALDH1A1LMNAL3MBTL1
SCHEMBL4520684 0.73 NQO1 (0.42) KDM4ENQO1PADI4CYP1A2ALDH1A1
SCHEMBL4520585 0.73 NQO1 (0.42) KDM4ENQO1PADI4CYP1A2ALDH1A1
SCHEMBL4520592 0.73 NQO1 (0.42) KDM4ENQO1PADI4CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143368-A1 Use of Cinnamoyl Compound COL2A1, COL1A1, SMAD2 MAPT 3377/4885KDM4E 1537/4885RAB9A 4027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.